These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 1037261)
1. Synthesis and pharmacological study of diphenylalkylamines with cycloaliphatic residues. New coronary vasodilators. Carenini G; Carissimi M; Gentili PG; Grumelli E; Piccióla G; Ravenna F Arzneimittelforschung; 1976; 26(12):2127-36. PubMed ID: 1037261 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and selective coronary vasodilatory activity of 3,4-dihydro-2,2-bis(methoxymethyl)-2H-1-benzopyran-3-ol derivatives: novel potassium channel openers. Cho H; Katoh S; Sayama S; Murakami K; Nakanishi H; Kajimoto Y; Ueno H; Kawasaki H; Aisaka K; Uchida I J Med Chem; 1996 Sep; 39(19):3797-805. PubMed ID: 8809167 [TBL] [Abstract][Full Text] [Related]
3. The pharmacology of diphenylalkyl derivatives. I. Comparative studies of coronary dilator diphenylalkylamine derivatives. Leszkovszky G; Tardos L; Erdély I; Harsányi K Acta Physiol Acad Sci Hung; 1966; 29(3):283-97. PubMed ID: 5923039 [No Abstract] [Full Text] [Related]
4. General pharmacology of the new antimuscarinic compound vamicamide. Yamamoto T; Honbo T; Tokoro K; Kojimoto Y; Kodama R; Ohtsuka M; Shimomura K Arzneimittelforschung; 1995 Dec; 45(12):1274-84. PubMed ID: 8595084 [TBL] [Abstract][Full Text] [Related]
5. [Studies on the mechanism of action of prenylamine]. Lindner E Arzneimittelforschung; 1969 Jan; 19(1):15-9. PubMed ID: 5819360 [No Abstract] [Full Text] [Related]
6. [Lidoflazine derivatives with cycloaliphatic residues of coronary dilator activity]. Carissimi M; Gentili P; Picciòla G; Ravenna F Farmaco Sci; 1977 Jun; 32(6):461-70. PubMed ID: 872926 [TBL] [Abstract][Full Text] [Related]
7. [Influence of some vasodilator agents on coronary flow]. Palazzoadriano M; Raineri A; Battaglia A; Profeta F; Cospite M; Casuccio L Boll Soc Ital Cardiol; 1970; 15(5):388-401. PubMed ID: 4145038 [No Abstract] [Full Text] [Related]
8. [On the method of action of new types of coronary dilatators with simultaneous oxygen-saving myocardial effects, prenylamine and iproveratril. 2]. Fleckenstein A; Kammermeier H; Döring HJ; Freund HJ Z Kreislaufforsch; 1967 Aug; 56(8):839-58. PubMed ID: 5592708 [No Abstract] [Full Text] [Related]
9. Cyclohexylphenoxy amidoximes and imidazolines with antidepressive and alpha-adrenergic activity. Picciòla G; Carissimi M; Ravenna F; Gentili P; Carenini G Arzneimittelforschung; 1979; 29(5):729-38. PubMed ID: 40574 [TBL] [Abstract][Full Text] [Related]
10. [Beta-sympathicolytic effect of derivatives of prenylamine]. Ehrhart G; Lindner E Arzneimittelforschung; 1968 Mar; 18(3):291-5. PubMed ID: 5696003 [No Abstract] [Full Text] [Related]
11. Effects of nilvadipine on the cardiovascular system in experimental animals. Ohtsuka M; Koibuchi Y; Sakai S; Tsujioka K; Fujiwara T; Ozaki T; Maeda K; Motoyama I; Horiai H; Ono T Arzneimittelforschung; 1988 Nov; 38(11):1605-18. PubMed ID: 3214444 [TBL] [Abstract][Full Text] [Related]
12. Cardiovascular actions of a prenylamine derivative of a new type. Leszkovszky GP; Tardos L; Korbonits D Agressologie; 1975; 16 Spec No B():41-7. PubMed ID: 1232827 [No Abstract] [Full Text] [Related]
13. [Experiments on the mechanism of action of vascular spasmolytic agents. II. Action of nitroprusside sodium, nitroglycerin, prenylamine and verapamil on the lanthanum contracture of isolated coronary arteries]. Fermum R; Klinner U; Meisel P Acta Biol Med Ger; 1976; 35(10):1359-64. PubMed ID: 828375 [TBL] [Abstract][Full Text] [Related]
14. Vasodilator action of KB-944, a new calcium antagonist. Morita T; Yoshino K; Kanazawa T; Ito K; Nose T Arzneimittelforschung; 1982; 32(9):1037-42. PubMed ID: 6890822 [TBL] [Abstract][Full Text] [Related]
15. Vasodilator activity of the aqueous extract of Viscum album. Tenorio FA; del Valle L; González A; Pastelín G Fitoterapia; 2005 Mar; 76(2):204-9. PubMed ID: 15752631 [TBL] [Abstract][Full Text] [Related]
16. Pharmacological analysis of the iridoid oleuropein. Petkov V; Manolov P Arzneimittelforschung; 1972 Sep; 22(9):1476-86. PubMed ID: 4678608 [No Abstract] [Full Text] [Related]
17. Effect of coronary vasodilators on cardiac dynamics of the normal dog and the dog with experimental coronary sclerosis. Saito D Jpn Circ J; 1976 Apr; 40(4):363-97. PubMed ID: 778426 [TBL] [Abstract][Full Text] [Related]
18. Verapamil: a selective antagonist of constrictor substances in dog coronary artery: implications for variant angina. Angus JA; Brazenor RM; Le Duc MA Clin Exp Pharmacol Physiol Suppl; 1982; 6():15-28. PubMed ID: 6956474 [TBL] [Abstract][Full Text] [Related]
19. General pharmacological properties of the new vasodilator flosequinan. Ikezono K; Fujita S; Umezato M; Hosoki E; Toba Y; Kusunoki A; Shintani S Arzneimittelforschung; 1992 Oct; 42(10):1200-11. PubMed ID: 1472141 [TBL] [Abstract][Full Text] [Related]